Browse medicines, page 3 of 9
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 121–180 of 526 records
Hyaluronidase (Vitrase / Amphadase / Hydase / Hylenex Recombinant)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Amphadase ® is an endoglycosidase indicated as an adjuvant: • in subcutaneous fluid administration for achieving hydration ( 1.1 ) • to increase absorption and dispersion of other injected drugs ( 1.2 ) • in subcutaneous urography for improving resorption of radiopaque agents ( 1.3 ) 1.1 Subcutaneous Fluid Administration Amphadase ® is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. 1.2 Dispersion and Absorption of Injected Drugs Amphadase ® is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs.
Hyaluronidase-Nvhy (Opdivo Qvantig)
Protein medicineApproved in the United States (FDA)Expanded recordInfliximab-Qbtx (Ixifi)
Protein medicineApproved in the United States (FDA)Expanded recordInfluenza A Virus A/Michigan/105/2025 San-049a Antigen (Fluzone Trivalent Northern Hemisphere / Fluzone High Dose Northern Hemisphere)
Protein medicineLaboratory or animal-stage researchExpanded recordInfluenza A Virus A/Singapore/Gp20238/2024 Ivr-277 Antigen (Fluzone Tiv Sh 2026 / Fluzone)
Protein medicineLaboratory or animal-stage researchExpanded recordInfluenza B Virus B/Michigan/01/2021 Antigen (Fluzone Tiv Sh 2026 / Fluzone Trivalent Northern Hemisphere / Fluzone / Fluzone High Dose Northern Hemisphere)
Protein medicineLaboratory or animal-stage researchExpanded recordInotuzumab Ozogamicin (Besponsa)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia
Insulin Aspart-Fsan (Garzulys)
Protein medicineApproved in the United States (FDA)Expanded recordInsulin-Like Growth Factor
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordInsulin-Like Growth Factor 1 Receptor (Dr Dale Wellness Nu Fem 1 2 3 All in One Topical Homeopathic)
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordUse listed on the medicine record
Topical gel, applied to skin
Insulin-Like Growth Factor-2 (Dr Dale Wellness Nu Fem 1 2 3 All in One Topical Homeopathic)
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordUse listed on the medicine record
Topical gel, applied to skin
Islelizumab-Jsgr (Tevimbra)
Protein medicineApproved in the United States (FDA)Expanded recordLapine T-Lymphocyte Immune Globulin (Thymoglobulin)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
The prophylaxis and treatment of acute rejection
Lumbrokinase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordMargetuximab-Cmkb (Margenza)
Protein medicineApproved in the United States (FDA)Expanded recordMucolase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordOxidase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordPancrelipase Protease (Creon / Zenpep / Pancreaze / Pertzye / Viokace)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy
Phosphatase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordPivekimab Sunirine (Decnupaz)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Blastic plasmacytoid dendritic cell neoplasm
Rilonacept (Arcalyst)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS), and Muckle-Wells Syndrome
Serine Proteinase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordSodium Chloride (Sodium Chloride 0.9% in Plastic Container / Natrum Muriaticum / Sodium Chloride 0.45% in Plastic Container / Bacteriostatic Sodium Chloride 0.9% in Plastic Container / Bacteriostatic Sodium Chloride / Resp Ease)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 10a Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Capvaxive / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordAlbumin Human (Albutein / Plasbumin / Albuked / Flexbumin / Albuminex / Alburx)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
And children
Alpha1-Proteinase Inhibitor Human (Prolastin-C Liquid / Glassia)
Protein medicineLaboratory or animal-stage researchExpanded recordAmylase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordAnifrolumab-Fnia (Saphnelo)
Protein medicineApproved in the United States (FDA)Expanded recordAsfotase alfa (Strensiq)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Perinatal/infantile- and juvenile-onset hypophosphatasia
Asparaginase Erwinia Chrysanthemi -Rywn (Rylaze)
Protein medicineApproved in the United States (FDA)Expanded recordBacillus Calmette-Guerin Substrain Tice Live Antigen (BCG Vaccine / Tice BCG)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
TICE ® BCG is indicated for: the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR) Limitations of Use: TICE BCG is not recommended for stage TaG1 papillary tumors, unless they are judged to be at high risk of tumor recurrence. TICE BCG is not indicated for papillary tumors of stages higher than T1.
Beractant (Survanta)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants
Bevacizumab-Vikg (Lytenava)
Protein medicineApproved in the United States (FDA)Expanded recordBrolucizumab-Dbll (Beovu)
Protein medicineApproved in the United States (FDA)Expanded recordBulevirtide-Gmod (Hepcludex)
Protein medicineApproved in the United States (FDA)Expanded recordCellulase (Stomach Enzyme Drops 2093)
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordCenegermin (Oxervate)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Neurotrophic keratitis
Cenegermin-Bkbj (Oxervate)
Protein medicineApproved in the United States (FDA)Expanded recordCipaglucosidase Alfa-Atga (Pombiliti)
Protein medicineApproved in the United States (FDA)Expanded recordClesrovimab-Cfor (Enflonsia)
Protein medicineApproved in the United States (FDA)Expanded recordCoagulation Factor X Human (Balfaxar)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Hereditary Factor X deficiency
Cocarboxylase (Enbrace Hr / Paxlyte)
Protein medicineUsed in a way not covered by an approval, or made by a compounding pharmacyExpanded recordUse listed on the medicine record
INDICATIONS: EnBrace HR ® is indicated in the TREATMENT of vitamin deficiency - specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate. Requirements of vitamin B 9 and/or vitamin B 12 in excess of normal due to pregnancy can usually be met with oral supplementation.
Datopotamab Deruxtecan (Datroway)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
DATROWAY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of: adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) who have received prior EGFR-directed therapy and platinum-based chemotherapy. ( 1.1 ) This indication is approved under accelerated approval based on objective response rate and duration of response [see Clinical Studies (14.1) ] .
Decarboxylase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordDenosumab-Mobz (Boncresa / Oziltus)
Protein medicineApproved in the United States (FDA)Expanded recordDonanemab-Azbt (Kisunla)
Protein medicineApproved in the United States (FDA)Expanded recordDostarlimab-Gxly (Jemperli)
Protein medicineApproved in the United States (FDA)Expanded recordEfbemalenograstim alfa (Ryzneuta)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
RYZNEUTA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. Limitations of Use RYZNEUTA is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Eflapegrastim-Xnst (Rolvedon)
Protein medicineApproved in the United States (FDA)Expanded recordElapegademase (Revcovi)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Adenosine deaminase severe combined immune deficiency
Enfortumab Vedotin (Padcev Ejfv)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Muscle invasive bladder cancer
Epoetin Alfa-Epbx (Retacrit)
Protein medicineApproved in the United States (FDA)Expanded recordFibrinolysin (Elase-Chloromycetin)
Protein medicineApproved in the United States (FDA)Expanded recordField Mushroom (Mushroom)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
BOTANICAL PURITY FOR A YOUTHFUL COMPLEXION SOOTHES, PROTECTS, AND BALANCES SENSITIVE SKIN It relieves dry, flaky skin and protects against irritation and harmful microbes, restoring balance to your skin.
Hemicellulase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordHemin (Panhematin)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
The amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after
Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen (Recombivax Hb / Heplisav-B)
Protein medicineLaboratory or animal-stage researchExpanded recordHuman Papillomavirus Type 31 L1 Capsid Protein Antigen (Gardasil 9)
Protein medicineLaboratory or animal-stage researchExpanded recordHuman Rotavirus A Type G3p7 Strain Wi78 Live Antigen (Rotateq)
Protein medicineLaboratory or animal-stage researchExpanded recordHuman Thrombin (Thrombin Human)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Use with manual compression